Skip to main content
Erschienen in: International Urology and Nephrology 3/2010

01.09.2010 | Nephrology - Review

Arterial stiffness in dialysis patients: where are we now?

verfasst von: Mehmet Kanbay, Baris Afsar, Paul Gusbeth-Tatomir, Adrian Covic

Erschienen in: International Urology and Nephrology | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Abstract

Patients with end-stage renal disease treated by chronic dialysis have an impressive mortality, which more than half of this mortality is attributable to cardiovascular disease. Despite stratification for sex, race, and the presence of diabetes, cardiovascular disease mortality is 10–30 times higher in dialysis patients compared to general population. In dialysis patients, both atherosclerosis (mainly affecting the intima of the arteries) and arteriosclerosis (affecting predominantly the media of large- and middle-sized arteries diffusely) are highly prominent. Arteriosclerosis characterized by reduced arterial compliance (i.e., reduced elasticity of the arteries) is due to increased fibrosis, loss of elastic fibers, and extensive vessel wall calcification. Arteriosclerosis is closely related to arterial stiffness. A generally accepted mechanistic view is that an increase in arterial stiffness causes a premature return of reflected waves in late systole, increasing central pulse pressure, thus systolic. An increased arterial stiffness can increase the risk of stroke through several mechanisms, including an increase in central pulse pressure, influencing arterial remodeling both at the site of the extracranial and intracranial arteries, increasing carotid wall thickness, and the development of stenosis and plaques, and the likelihood of plaque rupture. Very importantly, it was also suggested that arterial stiffness itself independently plays a role in exacerbating chronic kidney disease progression. This review deals briefly with the definition of arterial stiffness, methods of measuring arterial stiffness and pathophysiology of arterial stiffness, and factors related with arterial stiffness.
Literatur
1.
Zurück zum Zitat Foley RN, Parfrey PS, Sarnak MJ (1998) Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32:S112–S119CrossRefPubMed Foley RN, Parfrey PS, Sarnak MJ (1998) Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32:S112–S119CrossRefPubMed
2.
Zurück zum Zitat Gusbeth-Tatomir P, Covic A (2007) Causes and consequences of increased arterial stiffness in chronic kidney disease patients. Kidney Blood Press Res 30:97–107CrossRefPubMed Gusbeth-Tatomir P, Covic A (2007) Causes and consequences of increased arterial stiffness in chronic kidney disease patients. Kidney Blood Press Res 30:97–107CrossRefPubMed
3.
Zurück zum Zitat Covic A, Gusbeth-Tatomir P, Goldsmith DJ (2005) Arterial stiffness in renal patients: an update. Am J Kidney Dis 45:965–977CrossRefPubMed Covic A, Gusbeth-Tatomir P, Goldsmith DJ (2005) Arterial stiffness in renal patients: an update. Am J Kidney Dis 45:965–977CrossRefPubMed
4.
Zurück zum Zitat Laurent S et al (2006) Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 27:2588–2605CrossRefPubMed Laurent S et al (2006) Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 27:2588–2605CrossRefPubMed
5.
Zurück zum Zitat Boutouyrie P, Bussy C, Hayoz D, Hengstler J, Dartois N, Laloux B, Brunner H, Laurent S (2000) Local pulse pressure and regression of arterial wall hypertrophy during long term antihypertensive treatment. Circulation 101:2601–2606PubMed Boutouyrie P, Bussy C, Hayoz D, Hengstler J, Dartois N, Laloux B, Brunner H, Laurent S (2000) Local pulse pressure and regression of arterial wall hypertrophy during long term antihypertensive treatment. Circulation 101:2601–2606PubMed
6.
Zurück zum Zitat Zureik M, Ducimetiere P, Touboul PJ, Courbon D, Bonithon-Kopp C, Berr C, Magne C (2000) Common carotid intima-media thickness predicts occurrence of carotid atherosclerotic plaques longitudinal results from the ageing vascular study (EVA) study. Arterioscler Thromb Vasc Biol 20:1622–1629PubMed Zureik M, Ducimetiere P, Touboul PJ, Courbon D, Bonithon-Kopp C, Berr C, Magne C (2000) Common carotid intima-media thickness predicts occurrence of carotid atherosclerotic plaques longitudinal results from the ageing vascular study (EVA) study. Arterioscler Thromb Vasc Biol 20:1622–1629PubMed
7.
Zurück zum Zitat Cheng GC, Loree HM, Kamm RD, Fishbein MC, Lee RT (1993) Distribution of circumferential stress in ruptured and stable atherosclerotic lesions: a structural analysis with histopathological correlation. Circulation 87:1179–1187PubMed Cheng GC, Loree HM, Kamm RD, Fishbein MC, Lee RT (1993) Distribution of circumferential stress in ruptured and stable atherosclerotic lesions: a structural analysis with histopathological correlation. Circulation 87:1179–1187PubMed
8.
Zurück zum Zitat Taal MW, Sigrist MK, Fakis A, Fluck RJ, McIntyre CW (2007) Markers of arterial stiffness are risk factors for progression to end-stage renal disease among patients with chronic kidney disease stages 4 and 5. Nephron Clin Pract 107:c177–c181 Taal MW, Sigrist MK, Fakis A, Fluck RJ, McIntyre CW (2007) Markers of arterial stiffness are risk factors for progression to end-stage renal disease among patients with chronic kidney disease stages 4 and 5. Nephron Clin Pract 107:c177–c181
9.
Zurück zum Zitat Zoungas S, Asmar RP (2007) Arterial stiffness and cardiovascular outcome. Clin Exp Pharmacol Physiol 34:647–651CrossRefPubMed Zoungas S, Asmar RP (2007) Arterial stiffness and cardiovascular outcome. Clin Exp Pharmacol Physiol 34:647–651CrossRefPubMed
10.
11.
Zurück zum Zitat Asmar R, Benetos A, Topouchian J, Laurent P, Pannier B, Brisac AM, Target R, Levy BI (1995) Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies. Hypertension 26:485–490PubMed Asmar R, Benetos A, Topouchian J, Laurent P, Pannier B, Brisac AM, Target R, Levy BI (1995) Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies. Hypertension 26:485–490PubMed
12.
Zurück zum Zitat Van Bortel LM, Duprez D, Starmans-Kool MJ, Safar ME, Giannattasio C, Cockcroft J, Kaiser DR, Thuillez C (2002) Applications of arterial stiffness, Task Force III: recommendations for user procedures. Am J Hypertens 15:445–452CrossRefPubMed Van Bortel LM, Duprez D, Starmans-Kool MJ, Safar ME, Giannattasio C, Cockcroft J, Kaiser DR, Thuillez C (2002) Applications of arterial stiffness, Task Force III: recommendations for user procedures. Am J Hypertens 15:445–452CrossRefPubMed
13.
Zurück zum Zitat McEniery CM, Yasmin HallIR, Qasem A, Wilkinson IB, Cockcroft JR (2005) Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity: the Anglo-Cardiff Collaborative Trial (ACCT). J Am Coll Cardiol 46:1753–1760CrossRefPubMed McEniery CM, Yasmin HallIR, Qasem A, Wilkinson IB, Cockcroft JR (2005) Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity: the Anglo-Cardiff Collaborative Trial (ACCT). J Am Coll Cardiol 46:1753–1760CrossRefPubMed
14.
Zurück zum Zitat Nichols WW, O’Rourke MF (1998) Vascular impedance. In: Nichols WW, O’Rourke MF (ed) McDonald’s blood flow in arteries: theoretical, experimental and clinical principles. 4th edn. London: Edward Arnold, pp 54–97, 243–283, 347–395 Nichols WW, O’Rourke MF (1998) Vascular impedance. In: Nichols WW, O’Rourke MF (ed) McDonald’s blood flow in arteries: theoretical, experimental and clinical principles. 4th edn. London: Edward Arnold, pp 54–97, 243–283, 347–395
15.
Zurück zum Zitat Ratto E, Leoncini G, Viazzi F, Vaccaro V, Falqui V, Parodi A, Conti N, Tomolillo C, Deferrari G, Pontremoli R (2006) Ambulatory arterial stiffness index and renal abnormalities in primary hypertension. J Hypertens 24:2033–2038CrossRefPubMed Ratto E, Leoncini G, Viazzi F, Vaccaro V, Falqui V, Parodi A, Conti N, Tomolillo C, Deferrari G, Pontremoli R (2006) Ambulatory arterial stiffness index and renal abnormalities in primary hypertension. J Hypertens 24:2033–2038CrossRefPubMed
16.
Zurück zum Zitat Schillaci G, Parati G, Pirro M, Pucci G, Mannarino MR, Sperandini L, Mannarino E (2007) Ambulatory arterial stiffness ındex ıs not a specific marker of reduced arterial compliance. Hypertension 49:986–991CrossRefPubMed Schillaci G, Parati G, Pirro M, Pucci G, Mannarino MR, Sperandini L, Mannarino E (2007) Ambulatory arterial stiffness ındex ıs not a specific marker of reduced arterial compliance. Hypertension 49:986–991CrossRefPubMed
17.
Zurück zum Zitat Vogel RA, Benitez RM (2000) Noninvasive assessment of cardiovascular risk: from Framingham to the future. Rev Cardiovasc Med 1:34–42PubMed Vogel RA, Benitez RM (2000) Noninvasive assessment of cardiovascular risk: from Framingham to the future. Rev Cardiovasc Med 1:34–42PubMed
18.
Zurück zum Zitat Komai N, Ohishi M, Morishita R, Moriguchi A, Kaibe M, Matsumoto K, Rakugi H, Higaki J, Ogihara T (2002) Arterial stiffness index: a new evaluation for arterial stiffness in elderly patients with essential hypertension. Geriatric Geront Int 15:199–205 Komai N, Ohishi M, Morishita R, Moriguchi A, Kaibe M, Matsumoto K, Rakugi H, Higaki J, Ogihara T (2002) Arterial stiffness index: a new evaluation for arterial stiffness in elderly patients with essential hypertension. Geriatric Geront Int 15:199–205
19.
Zurück zum Zitat Hiramatsu K, Oiwa A, Shigematsu S et al (2004) A novel arterial stiffness index (ASI) as a marker of arteriosclerosis. Am J Hypertens 17:131ACrossRef Hiramatsu K, Oiwa A, Shigematsu S et al (2004) A novel arterial stiffness index (ASI) as a marker of arteriosclerosis. Am J Hypertens 17:131ACrossRef
20.
Zurück zum Zitat Kocak H, Gumuslu S, Sahin E, Ceken K, Ermis C, Gocmen AY, Yakupoglu G, Ersoy FF, Suleymanlar G, Tuncer M (2009) Relationship between carotid artery intima-media thickness and brachial artery flow-mediated dilation in peritoneal dialysis patients. Int Urol Nephrol 41(2):409–416CrossRefPubMed Kocak H, Gumuslu S, Sahin E, Ceken K, Ermis C, Gocmen AY, Yakupoglu G, Ersoy FF, Suleymanlar G, Tuncer M (2009) Relationship between carotid artery intima-media thickness and brachial artery flow-mediated dilation in peritoneal dialysis patients. Int Urol Nephrol 41(2):409–416CrossRefPubMed
21.
Zurück zum Zitat Adragão T, Pires A, Birne R, Curto JD, Lucas C, Gonçalves M, Negrão AP (2009) A plain X-ray vascular calcification score is associated with arterial stiffness and mortality in dialysis patients. Nephrol Dial Transplant 24(3):997–1002CrossRefPubMed Adragão T, Pires A, Birne R, Curto JD, Lucas C, Gonçalves M, Negrão AP (2009) A plain X-ray vascular calcification score is associated with arterial stiffness and mortality in dialysis patients. Nephrol Dial Transplant 24(3):997–1002CrossRefPubMed
22.
Zurück zum Zitat Mark PB, Doyle A, Blyth KG, Patel RK, Weir RA, Steedman T, Foster JE, Dargie HJ, Jardine AG (2008) Vascular function assessed with cardiovascular magnetic resonance predicts survival in patients with advanced chronic kidney disease. J Cardiovasc Magn Reson 10(1):39CrossRefPubMed Mark PB, Doyle A, Blyth KG, Patel RK, Weir RA, Steedman T, Foster JE, Dargie HJ, Jardine AG (2008) Vascular function assessed with cardiovascular magnetic resonance predicts survival in patients with advanced chronic kidney disease. J Cardiovasc Magn Reson 10(1):39CrossRefPubMed
23.
Zurück zum Zitat London GM, Marchais SJ, Guerin AP, Metivier F (2002) Impairment of arterial function in chronic renal disease: prognostic impact and therapeutic approach. Nephrol Dial Transplant 12:13–15 London GM, Marchais SJ, Guerin AP, Metivier F (2002) Impairment of arterial function in chronic renal disease: prognostic impact and therapeutic approach. Nephrol Dial Transplant 12:13–15
24.
Zurück zum Zitat Mourad JJ, Pannier B, Blacher J et al (2001) Creatinine clearance, pulse wave velocity, carotid compliance and essential hypertension. Kidney Int 59:1834–1841CrossRefPubMed Mourad JJ, Pannier B, Blacher J et al (2001) Creatinine clearance, pulse wave velocity, carotid compliance and essential hypertension. Kidney Int 59:1834–1841CrossRefPubMed
25.
Zurück zum Zitat Benetos A, Adamopoulos C, Bureau JM et al (2002) Determinants of accelerated progression of arterial stiffness in normotensive subjects and in treated hypertensive subjects over a 6-year period. Circulation 105:1202–1207CrossRefPubMed Benetos A, Adamopoulos C, Bureau JM et al (2002) Determinants of accelerated progression of arterial stiffness in normotensive subjects and in treated hypertensive subjects over a 6-year period. Circulation 105:1202–1207CrossRefPubMed
26.
Zurück zum Zitat Makita Z, Bucala R, Rayfield EJ, Friedman EA, Kaufman AM, Korbet SM, Barth RH, Winston JA, Fuh H, Manogue KR et al (1994) Reactive glycosylation end-products in diabetic uremia and treatment of renal failure. Lancet 343:1519–1522CrossRefPubMed Makita Z, Bucala R, Rayfield EJ, Friedman EA, Kaufman AM, Korbet SM, Barth RH, Winston JA, Fuh H, Manogue KR et al (1994) Reactive glycosylation end-products in diabetic uremia and treatment of renal failure. Lancet 343:1519–1522CrossRefPubMed
27.
Zurück zum Zitat Miyata T, de Strihou C, Kurokawa K, Baynes JW (1999) Alterations in nonenzymatic biochemistry in uremia: origin and significance of ‘carbonyl stress’ in long-term uremic complications. Kidney Int 55:389–399CrossRefPubMed Miyata T, de Strihou C, Kurokawa K, Baynes JW (1999) Alterations in nonenzymatic biochemistry in uremia: origin and significance of ‘carbonyl stress’ in long-term uremic complications. Kidney Int 55:389–399CrossRefPubMed
28.
Zurück zum Zitat Tycho Vuurmans JL, Boer WH, Bos WJ, Blankestijn PJ, Koomans HA (2002) Contribution of volume overload and angiotensin II to the increase pulse wave velocity of hemodialysis patients. J Am Soc Nephrol 13:177–183PubMed Tycho Vuurmans JL, Boer WH, Bos WJ, Blankestijn PJ, Koomans HA (2002) Contribution of volume overload and angiotensin II to the increase pulse wave velocity of hemodialysis patients. J Am Soc Nephrol 13:177–183PubMed
29.
Zurück zum Zitat Lin YP, Yu WC, Hsu TL, Ding PY, Yang WC, Chen CH (2003) The extracellular fluid-to-intracellular fluid volume ratio is associated with large-artery structure and function in hemodialysis patients. Am J Kidney Dis 42:990–999CrossRefPubMed Lin YP, Yu WC, Hsu TL, Ding PY, Yang WC, Chen CH (2003) The extracellular fluid-to-intracellular fluid volume ratio is associated with large-artery structure and function in hemodialysis patients. Am J Kidney Dis 42:990–999CrossRefPubMed
30.
Zurück zum Zitat Kobayashi S, Okamoto K, Maesato K, Moriya H, Ohtake T (2005) Important role of blood rheology in atherosclerosis of patients with hemodialysis. Hemodial Int 9:268–274CrossRefPubMed Kobayashi S, Okamoto K, Maesato K, Moriya H, Ohtake T (2005) Important role of blood rheology in atherosclerosis of patients with hemodialysis. Hemodial Int 9:268–274CrossRefPubMed
31.
Zurück zum Zitat Cheng LT, Tang LJ, Chen HM, Tang W, Wang T (2008) Relationship between serum albumin and pulse wave velocity in patients on continuous ambulatory peritoneal dialysis. Vasc Health Risk Manag 4(4):871–876PubMed Cheng LT, Tang LJ, Chen HM, Tang W, Wang T (2008) Relationship between serum albumin and pulse wave velocity in patients on continuous ambulatory peritoneal dialysis. Vasc Health Risk Manag 4(4):871–876PubMed
32.
Zurück zum Zitat London GM, Marchais SJ, Safar ME, Genest AF, Guerin AP, Metivier F, Chedid K, London AM (1990) Aortic and large artery compliance in end-stage renal failure. Kidney Int 37:137–142CrossRefPubMed London GM, Marchais SJ, Safar ME, Genest AF, Guerin AP, Metivier F, Chedid K, London AM (1990) Aortic and large artery compliance in end-stage renal failure. Kidney Int 37:137–142CrossRefPubMed
33.
Zurück zum Zitat Nakamura T, Kawagoe Y, Matsuda T, Takahashi Y, Sekizuka K, Ebihara I, Koide H (2003) Effects of LDL apheresis and vitamin E-modified membrane on carotid atherosclerosis in hemodialyzed patients with arteriosclerosis obliterans. Kidney Blood Press Res 26:185–191CrossRefPubMed Nakamura T, Kawagoe Y, Matsuda T, Takahashi Y, Sekizuka K, Ebihara I, Koide H (2003) Effects of LDL apheresis and vitamin E-modified membrane on carotid atherosclerosis in hemodialyzed patients with arteriosclerosis obliterans. Kidney Blood Press Res 26:185–191CrossRefPubMed
34.
Zurück zum Zitat Moe SM, Reslerova M, Ketteler M, O’Neill K, Duan D, Koczman J, Westenfeld R, Jahnen-Dechent W, Chen NX (2005) Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease. Kidney Int 67:2295–2304CrossRefPubMed Moe SM, Reslerova M, Ketteler M, O’Neill K, Duan D, Koczman J, Westenfeld R, Jahnen-Dechent W, Chen NX (2005) Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease. Kidney Int 67:2295–2304CrossRefPubMed
35.
Zurück zum Zitat Wang AY, Woo J, Lam CW, Wang M, Chan IH, Gao P, Lui SF, Li PK, Sanderson JE (2005) Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients. Nephrol DialTransplant 20:1676–1685 Wang AY, Woo J, Lam CW, Wang M, Chan IH, Gao P, Lui SF, Li PK, Sanderson JE (2005) Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients. Nephrol DialTransplant 20:1676–1685
36.
Zurück zum Zitat Cozzolino M, Brancaccio D, Gallieni M, Slatopolsky E (2005) Pathogenesis of vascular calcification in chronic kidney disease. Kidney Int 68:429–436CrossRefPubMed Cozzolino M, Brancaccio D, Gallieni M, Slatopolsky E (2005) Pathogenesis of vascular calcification in chronic kidney disease. Kidney Int 68:429–436CrossRefPubMed
37.
Zurück zum Zitat Goldsmith DJ, Covic A, Sambrook PA, Ackrill P (1997) Vascular calcification in long-term hemodialysis patients in a single unit: a retrospective analysis. Nephron 77:37–43CrossRefPubMed Goldsmith DJ, Covic A, Sambrook PA, Ackrill P (1997) Vascular calcification in long-term hemodialysis patients in a single unit: a retrospective analysis. Nephron 77:37–43CrossRefPubMed
38.
Zurück zum Zitat Reynolds JL, Joannides AJ, Skepper JN, Mc-Nair R, Schurgers LJ, Proudfoot D, Jahnen-Dechent W, Weissberg PL, Shanahan CM (2004) Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol 15:2857–2867CrossRefPubMed Reynolds JL, Joannides AJ, Skepper JN, Mc-Nair R, Schurgers LJ, Proudfoot D, Jahnen-Dechent W, Weissberg PL, Shanahan CM (2004) Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol 15:2857–2867CrossRefPubMed
39.
Zurück zum Zitat Tintut Y, Patel J, Territo M, Saini T, Parhami F, Demer LL (2002) Monocyte/macrophage regulation of vascular calcification in vitro. Circulation 105:650–655CrossRefPubMed Tintut Y, Patel J, Territo M, Saini T, Parhami F, Demer LL (2002) Monocyte/macrophage regulation of vascular calcification in vitro. Circulation 105:650–655CrossRefPubMed
40.
Zurück zum Zitat Tintut Y, Patel J, Parhami F, Demer LL (2000) Tumor necrosis factor- alpha promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation 102:2636–2642PubMed Tintut Y, Patel J, Parhami F, Demer LL (2000) Tumor necrosis factor- alpha promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation 102:2636–2642PubMed
41.
Zurück zum Zitat Wang AY, Woo J, Wang M, Sea MM, Ip R, Li PK, Lui SF, Sanderson JE (2001) Association of inflammation and malnutrition with cardiac valve calcification in continuous ambulatory peritoneal dialysis patients. J Am Soc Nephrol 12:1927–1936PubMed Wang AY, Woo J, Wang M, Sea MM, Ip R, Li PK, Lui SF, Sanderson JE (2001) Association of inflammation and malnutrition with cardiac valve calcification in continuous ambulatory peritoneal dialysis patients. J Am Soc Nephrol 12:1927–1936PubMed
42.
Zurück zum Zitat Haydar AA, Hujairi NM, Covic AA, Pereira D, Rubens M, Goldsmith DJ (2004) Coronary artery calcification is related to coronary atherosclerosis in chronic renal disease patients: a study comparing EBCT-generated coronary artery calcium scores and coronary angiography. Nephrol Dial Transplant 19:2307–2312CrossRefPubMed Haydar AA, Hujairi NM, Covic AA, Pereira D, Rubens M, Goldsmith DJ (2004) Coronary artery calcification is related to coronary atherosclerosis in chronic renal disease patients: a study comparing EBCT-generated coronary artery calcium scores and coronary angiography. Nephrol Dial Transplant 19:2307–2312CrossRefPubMed
43.
Zurück zum Zitat Kullo IJ, Bielak LF, Turner ST, Sheedy PF 2nd, Peyser PA (2006) Aortic pulse wave velocity is associated with the presence and quantity of coronary artery calcium. A communitybased study. Hypertension 47:174–179CrossRefPubMed Kullo IJ, Bielak LF, Turner ST, Sheedy PF 2nd, Peyser PA (2006) Aortic pulse wave velocity is associated with the presence and quantity of coronary artery calcium. A communitybased study. Hypertension 47:174–179CrossRefPubMed
44.
Zurück zum Zitat Guérin AP, London GM, Marchais SJ, Metivier F (2000) Arterialstiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant 15:1014–1021CrossRefPubMed Guérin AP, London GM, Marchais SJ, Metivier F (2000) Arterialstiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant 15:1014–1021CrossRefPubMed
45.
Zurück zum Zitat London GM, Blacher J, Pannier B, Guérin AP, Marchais SJ, Safar ME (2001) Impact of aortic stiffness attenuation on survival of patients in endstage renal failure. Circulation 103:987–992PubMed London GM, Blacher J, Pannier B, Guérin AP, Marchais SJ, Safar ME (2001) Impact of aortic stiffness attenuation on survival of patients in endstage renal failure. Circulation 103:987–992PubMed
46.
Zurück zum Zitat Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM (2001) Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 38:938–942CrossRefPubMed Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM (2001) Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 38:938–942CrossRefPubMed
47.
Zurück zum Zitat Fang W, Yang X, Bargman JM, Oreopoulos DG (2009) Association between pulse pressure and mortality in patients undergoing peritoneal dialysis. Perit Dial Int 29(2):163–170PubMed Fang W, Yang X, Bargman JM, Oreopoulos DG (2009) Association between pulse pressure and mortality in patients undergoing peritoneal dialysis. Perit Dial Int 29(2):163–170PubMed
48.
Zurück zum Zitat Ogawa T, Shimada M, Ishida H, Matsuda N, Fujiu A, Ando Y, Nitta K (2009) Relation of stiffness parameter beta to carotid arteriosclerosis and silent cerebral infarction in patients on chronic hemodialysis. Int Urol Nephrol 41(3):739–745CrossRefPubMed Ogawa T, Shimada M, Ishida H, Matsuda N, Fujiu A, Ando Y, Nitta K (2009) Relation of stiffness parameter beta to carotid arteriosclerosis and silent cerebral infarction in patients on chronic hemodialysis. Int Urol Nephrol 41(3):739–745CrossRefPubMed
49.
Zurück zum Zitat Haydar AA, Covic A, Colhoun H, Rubens M, Goldsmith DJ (2004) Coronary artery calcification and aortic pulse wave velocity in chronic kidney disease patients. Kidney Int 65:1790–1794CrossRefPubMed Haydar AA, Covic A, Colhoun H, Rubens M, Goldsmith DJ (2004) Coronary artery calcification and aortic pulse wave velocity in chronic kidney disease patients. Kidney Int 65:1790–1794CrossRefPubMed
50.
Zurück zum Zitat London GM, Marchais SJ, Guérin AP, Boutouyrie P, Métivier F, de Vernejoul MC (2008) Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD. J Am Soc Nephrol 19:1827–1835CrossRefPubMed London GM, Marchais SJ, Guérin AP, Boutouyrie P, Métivier F, de Vernejoul MC (2008) Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD. J Am Soc Nephrol 19:1827–1835CrossRefPubMed
51.
Zurück zum Zitat Bossola M, Muscaritoli M, Tazza L, Giungi S, Tortorelli A, Rossi Fanelli F, Luciani G (2005) Malnutrition in hemodialysis patients: what therapy? Am J Kidney Dis 46:371–386CrossRefPubMed Bossola M, Muscaritoli M, Tazza L, Giungi S, Tortorelli A, Rossi Fanelli F, Luciani G (2005) Malnutrition in hemodialysis patients: what therapy? Am J Kidney Dis 46:371–386CrossRefPubMed
52.
Zurück zum Zitat Gu Yue, Cheng Li-Tao, Chen Hui-Min, Sun Xiao-Yan, Tang Li-Jun, Guo Li-Juan, Axelsson Jonas, Wang Tao (2008) Strong association between nutritional markers and arterial stiffness in continuous ambulatory peritoneal dialysis patients. Blood Purif 26:340–346CrossRefPubMed Gu Yue, Cheng Li-Tao, Chen Hui-Min, Sun Xiao-Yan, Tang Li-Jun, Guo Li-Juan, Axelsson Jonas, Wang Tao (2008) Strong association between nutritional markers and arterial stiffness in continuous ambulatory peritoneal dialysis patients. Blood Purif 26:340–346CrossRefPubMed
53.
Zurück zum Zitat Schafer C, Heiss A, Schwarz A et al (2003) The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 112:357–366PubMed Schafer C, Heiss A, Schwarz A et al (2003) The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 112:357–366PubMed
54.
Zurück zum Zitat Jahnen-Dechent W, Schinke T, Trindl A, Müller-Esterl W, Sablitzky F, Kaiser S, Blessing M (1997) Cloning and targeted deletion of the mouse fetuin gene. J Biol Chem 272:31496–31503CrossRefPubMed Jahnen-Dechent W, Schinke T, Trindl A, Müller-Esterl W, Sablitzky F, Kaiser S, Blessing M (1997) Cloning and targeted deletion of the mouse fetuin gene. J Biol Chem 272:31496–31503CrossRefPubMed
55.
56.
Zurück zum Zitat Hermans MM, Brandenburg V, Ketteler M, Kooman JP, van der Sande FM, Gladziwa U, Rensma PL, Bartelet K, Konings CJ, Hoeks AP, Floege J, Leunissen KM (2006) Study on the relationship of serum fetuin-A concentration with aortic stiffness in patients on dialysis. Nephrol Dial Transplant 21:1293–1299CrossRefPubMed Hermans MM, Brandenburg V, Ketteler M, Kooman JP, van der Sande FM, Gladziwa U, Rensma PL, Bartelet K, Konings CJ, Hoeks AP, Floege J, Leunissen KM (2006) Study on the relationship of serum fetuin-A concentration with aortic stiffness in patients on dialysis. Nephrol Dial Transplant 21:1293–1299CrossRefPubMed
57.
Zurück zum Zitat Sigrist MhairiK, Taal MaartenW, Bungay Peter, Christopher W (2007) McIntyre progressive vascular calcification over 2 years ıs associated with arterial stiffening and ıncreased mortality in patients with stages 4 and 5 chronic kidney disease. Clin J Am Soc Nephrol 2:1241–1248CrossRefPubMed Sigrist MhairiK, Taal MaartenW, Bungay Peter, Christopher W (2007) McIntyre progressive vascular calcification over 2 years ıs associated with arterial stiffening and ıncreased mortality in patients with stages 4 and 5 chronic kidney disease. Clin J Am Soc Nephrol 2:1241–1248CrossRefPubMed
58.
Zurück zum Zitat Chesterton LJ, Sigrist MK, Bennett T, Taal MW, McIntyre CW (2005) Reduced baroreflex sensitivity is associated with increased vascular calcification and arterial stiffness. Nephrol Dial Transplant 20:1140–1147CrossRefPubMed Chesterton LJ, Sigrist MK, Bennett T, Taal MW, McIntyre CW (2005) Reduced baroreflex sensitivity is associated with increased vascular calcification and arterial stiffness. Nephrol Dial Transplant 20:1140–1147CrossRefPubMed
59.
Zurück zum Zitat Hermans MM, Vermeer C, Kooman JP, Brandenburg V, Ketteler M, Gladziwa U, Rensma PL, Leunissen KM, Schurgers LJ (2007) Undercarboxylated matrix GLA protein levels are decreased in dialysis patients and related to parameters of calcium-phosphate metabolism and aortic augmentation ındex. Blood Purif 25:395–401CrossRefPubMed Hermans MM, Vermeer C, Kooman JP, Brandenburg V, Ketteler M, Gladziwa U, Rensma PL, Leunissen KM, Schurgers LJ (2007) Undercarboxylated matrix GLA protein levels are decreased in dialysis patients and related to parameters of calcium-phosphate metabolism and aortic augmentation ındex. Blood Purif 25:395–401CrossRefPubMed
60.
Zurück zum Zitat Wilkinson IB, Franklin SS, Cockcroft JR (2004) Nitric oxide and the regulation of large artery stiffness: from physiology to pharmacology. Hypertension 44:112–116CrossRefPubMed Wilkinson IB, Franklin SS, Cockcroft JR (2004) Nitric oxide and the regulation of large artery stiffness: from physiology to pharmacology. Hypertension 44:112–116CrossRefPubMed
61.
Zurück zum Zitat Kielstein JT, Böger RH, Bode-Böger SM, Schäffer J, Barbey M, Koch KM, Frölich JC (1999) Asymmetric dimethylarginine plasma concentrations differ in patients with endstage renal disease: Relationship to treatment method and atherosclerotic disease. J Am Soc Nephrol 10:594–600PubMed Kielstein JT, Böger RH, Bode-Böger SM, Schäffer J, Barbey M, Koch KM, Frölich JC (1999) Asymmetric dimethylarginine plasma concentrations differ in patients with endstage renal disease: Relationship to treatment method and atherosclerotic disease. J Am Soc Nephrol 10:594–600PubMed
62.
Zurück zum Zitat Mardare NG, Goldsmith DJ, Gusbeth-Tatomir P, Covic A (2005) Intradialytic changes in reflective properties of the arterial system during a single hemodialysis session. Hemodial Int 9:376–382CrossRefPubMed Mardare NG, Goldsmith DJ, Gusbeth-Tatomir P, Covic A (2005) Intradialytic changes in reflective properties of the arterial system during a single hemodialysis session. Hemodial Int 9:376–382CrossRefPubMed
63.
Zurück zum Zitat Wikström IngaSoveriLarsLindBjörn, Zilmer Mihkel, Zilmer Kersti, Fellström Bengt (2007) Improvement in central arterial pressure waveform during hemodialysis ıs related to a reduction in asymmetric dimethylarginine (ADMA) levels. Nephron Clin Pract 106:c180–c186CrossRefPubMed Wikström IngaSoveriLarsLindBjörn, Zilmer Mihkel, Zilmer Kersti, Fellström Bengt (2007) Improvement in central arterial pressure waveform during hemodialysis ıs related to a reduction in asymmetric dimethylarginine (ADMA) levels. Nephron Clin Pract 106:c180–c186CrossRefPubMed
64.
Zurück zum Zitat Blacher J, Demuth K, Guerin AP, Safar ME, Moatti N, London GM (1998) Influence of biochemical alterations on arterial stiffness in patients with end-stage renal disease. Arterioscler Thromb Vasc Biol 18:535–541PubMed Blacher J, Demuth K, Guerin AP, Safar ME, Moatti N, London GM (1998) Influence of biochemical alterations on arterial stiffness in patients with end-stage renal disease. Arterioscler Thromb Vasc Biol 18:535–541PubMed
65.
Zurück zum Zitat van Guldener C, Lambert J, ter Wee PM, Donker AJ, Stehouwer CD (2000) Carotid artery stiffness in patients with end-stage renal disease: no effect of long-term homocysteine-lowering therapy. Clin Nephrol 53:33–41PubMed van Guldener C, Lambert J, ter Wee PM, Donker AJ, Stehouwer CD (2000) Carotid artery stiffness in patients with end-stage renal disease: no effect of long-term homocysteine-lowering therapy. Clin Nephrol 53:33–41PubMed
66.
Zurück zum Zitat Tsai JC, Kuo HT, Chiu YW, Hwang SJ, Chuang HY, Chang JM, Chen HC, Lai YH (2005) Correlation of plasma homocysteine level with arterial stiffness and pulse pressure in hemodialysis patients. Atherosclerosis 182:121–127CrossRefPubMed Tsai JC, Kuo HT, Chiu YW, Hwang SJ, Chuang HY, Chang JM, Chen HC, Lai YH (2005) Correlation of plasma homocysteine level with arterial stiffness and pulse pressure in hemodialysis patients. Atherosclerosis 182:121–127CrossRefPubMed
67.
Zurück zum Zitat London GM, Guerin AP, Verbeke FH, Pannier B, Boutouyrie P, Marchais SJ, Metivier F (2007) Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency. J Am Soc Nephrol 18:369–373CrossRef London GM, Guerin AP, Verbeke FH, Pannier B, Boutouyrie P, Marchais SJ, Metivier F (2007) Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency. J Am Soc Nephrol 18:369–373CrossRef
68.
Zurück zum Zitat Raggi P, Bellasi A, Ferramosca E, Block GA, Muntner P (2007) Pulse wave velocity is inversely related to vertebral bone density in hemodialysis patients. Hypertension 49:1278–1284CrossRefPubMed Raggi P, Bellasi A, Ferramosca E, Block GA, Muntner P (2007) Pulse wave velocity is inversely related to vertebral bone density in hemodialysis patients. Hypertension 49:1278–1284CrossRefPubMed
69.
Zurück zum Zitat Toussaint ND, Lau KK, Strauss BJ, Polkinghorne KR, Kerr PG (2008) Associations between vascular calcification, arterial stiffness and bonemineral density in chronic kidney disease. Nephrol Dial Transplant 23(2):586–593CrossRefPubMed Toussaint ND, Lau KK, Strauss BJ, Polkinghorne KR, Kerr PG (2008) Associations between vascular calcification, arterial stiffness and bonemineral density in chronic kidney disease. Nephrol Dial Transplant 23(2):586–593CrossRefPubMed
70.
Zurück zum Zitat Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, Takeuchi Y, Fujita T, Nakahara K, Fukumoto S, Yamashita T (2004) FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 19:429–435CrossRefPubMed Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, Takeuchi Y, Fujita T, Nakahara K, Fukumoto S, Yamashita T (2004) FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 19:429–435CrossRefPubMed
71.
Zurück zum Zitat Shimada T, Mizutani S, Muto T, Yoneya T, Hino R, Takeda S, Takeuchi Y, Fujita T, Fukumoto S, Yamashita T (2001) Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci USA 98:6500–6505CrossRefPubMed Shimada T, Mizutani S, Muto T, Yoneya T, Hino R, Takeda S, Takeuchi Y, Fujita T, Fukumoto S, Yamashita T (2001) Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci USA 98:6500–6505CrossRefPubMed
72.
Zurück zum Zitat Larsson T, Nisbeth U, Ljunggren O, Juppner H, Jonsson KB (2003) Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers. Kidney Int 64(6):2272–2279CrossRefPubMed Larsson T, Nisbeth U, Ljunggren O, Juppner H, Jonsson KB (2003) Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers. Kidney Int 64(6):2272–2279CrossRefPubMed
73.
Zurück zum Zitat Gutiérrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, Shah A, Smith K, Lee H, Thadhani R, Jüppner H, Wolf M (2008) Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 359:584–592CrossRefPubMed Gutiérrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, Shah A, Smith K, Lee H, Thadhani R, Jüppner H, Wolf M (2008) Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 359:584–592CrossRefPubMed
74.
Zurück zum Zitat Mirza MA, Larsson A, Lind L, Larsson TE (2009) Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community. Atherosclerosis 205:385–390 Mirza MA, Larsson A, Lind L, Larsson TE (2009) Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community. Atherosclerosis 205:385–390
75.
Zurück zum Zitat Tzanakis IP, Oreopoulos DG (2009) Beneficial effects of magnesium in chronic renal failure: a foe no longer. Int Urol Nephrol 41(2):363–371CrossRefPubMed Tzanakis IP, Oreopoulos DG (2009) Beneficial effects of magnesium in chronic renal failure: a foe no longer. Int Urol Nephrol 41(2):363–371CrossRefPubMed
76.
Zurück zum Zitat Turgut F, Kanbay M, Metin MR, Uz E, Akcay A, Covic A (2008) Magnesium supplementation helps to improve carotid intima media thickness in patients on hemodialysis. Int Urol Nephrol 40(4):1075–1082CrossRefPubMed Turgut F, Kanbay M, Metin MR, Uz E, Akcay A, Covic A (2008) Magnesium supplementation helps to improve carotid intima media thickness in patients on hemodialysis. Int Urol Nephrol 40(4):1075–1082CrossRefPubMed
Metadaten
Titel
Arterial stiffness in dialysis patients: where are we now?
verfasst von
Mehmet Kanbay
Baris Afsar
Paul Gusbeth-Tatomir
Adrian Covic
Publikationsdatum
01.09.2010
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 3/2010
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-009-9675-1

Weitere Artikel der Ausgabe 3/2010

International Urology and Nephrology 3/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.